|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.67 HKD | -0.87% |
|
+1.61% | +18.87% |
Consun Pharmaceutical Group Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 993.53 million compared to CNY 886.53 million a year ago. Net income was CNY 296.73 million compared to CNY 250.64 million a year ago.
Basic earnings per share from continuing operations was CNY 0.3743 compared to CNY 0.3132 a year ago. Diluted earnings per share from continuing operations was CNY 0.3733 compared to CNY 0.3117 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +18.87% | 575M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
CONSUN PHARMACEUTICAL GROUP LIMITED 
